Skip to main content
. 2022 Jan 14;33(5):1037–1055. doi: 10.1007/s00198-021-06281-y

Table 3.

Medical history

Women n = 91 Men n = 127 Total n = 218
Any previous disease 65 (71%) 79 (62%) 144 (66%)
Patients with specific disease(s) potentially associated with hip fracture a 52 (57%) 53 (42%) 105 (48%)
Patients with any other disease(s) 49 (54%) 49 (39%) 98 (45%)
Comorbidity (potentially hip fracture associated and other diseases) Women n = 91 Men n = 127 Total n = 218
No previous disease 26 (29%) 48 (38%) 74 (34%)
1 comorbidity 25 (28%) 43 (34%) 68 (31%)
2 comorbidities 12 (13%) 20 (16%) 32 (15%)
3 comorbidities 10 (11%) 10 (8%) 20 (9%)
4 comorbidities 8 (9%) 3 (2%) 11 (5%)
5 comorbidities 6 (7%) 1 (1%) 7 (3%)
6 comorbidities 1 (1%) 1 (1%) 2 (1%)
7 comorbidities 1 (1%) 1 (1%) 2 (1%)
8 comorbidities 2 (2%) 0 2 (1%)
ASA classification Women n = 91 Men n = 127 Total n = 218
ASA I 16 (18%) 44 (35%) 60 (28%)
ASA II 42 (46%) 44 (35%) 86 (39%)
ASA III 31 (34%) 35 (28%) 66 (30%)
ASA IV 2 (2%) 4 (3%) 6 (3%)
Hospital admission Women n = 90 Men n = 124 Total n = 214
Hospital admission within last year 24 (27%) 27 (22%) 51 (24%)
Previous hip fracture Women n = 90 Men n = 124 Total n = 214
Yes, contralateral 3 (3%) 6 (5%) 9 (4%)
Yes, ipsilateral 0 1 (1%) 1 (.5%)
Previous fracture (after 20 years of age) Women n = 87 Men n = 121 Total n = 208
Previous other fracture 44 (51%) 53 (44%) 97 (47%)
Fragility fracture in the family Women n = 86 Men n = 123 Total n = 209
Yes 21 (24%) 14 (11%) 35 (17%)
No 49 (57%) 82 (67%) 131 (63%)
Do not know 16 (19%) 27 (22%) 43 (21%)

aSpecific diseases potentially associated with hip fracture are specified in Appendix Table 5